Public Benefit as Bootstrapping
Numinus & Field Trip: A Tale of Two Strategies Announcements from Numinus and Field Trip highlight two different approaches and two different challenge…
Zach Haigney
With COMPASS Pathways' listing and early success on NASDAQ, a clear precedent is set. The premise of psychedelic medicine has been accepted by more ext…
Zach Haigney
Psychedelic Business News Roundup In Partnership with Lucid News UC Berkeley Center for the Science of Psychedelics “To the psychologist, the religious…
Zach Haigney
If psychedelics and their potential for healing and personal transformation weren't compelling enough, this re-emergence/renaissance is happening again…
Zach Haigney
There are mile markers along the highway to medicalization and the mainstream that are obvious and notable like Breakthrough Therapy Designation, filin…
Zach Haigney
Psychedelic Business News Roundup In Partnership with Lucid News Starting today, Wednesday’s Trip Report and psychedelic business news round-up will be…
Zach Haigney
Mind Medicine Australia Submits Application for MDMA and Psilocybin Rescheduling In the same week that COMPASS announced IPO plans and Esketamine was a…
Zach Haigney
See all